SAM #HT941026N0096

Sole Source Notice: Boston Scientific Y-90 Glass TheraSpheres for Tripler Army Medical Center

This notice announces the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division West's intent to award a sole-source contract for specialized cancer treatment supplies. - Sole-source procurement to Boston Scientific Corp for Y-90 Glass TheraSpheres - TheraSpheres are radioactive glass microspheres used in targeted radiation therapy for liver cancer - Intended for Tripler Army Medical Center's Department of Radiology in Hawaii - Boston Scientific is the only FDA-approved manufacturer and sole U.S. distributor for this product - Contract includes a base year (Oct 1, 2026 – Sep 30, 2027) plus four option years (through Sep 30, 2031) - No product quantities or part numbers specified in the notice - No set-aside or competitive bidding; procurement justified by sole source status - Commercial opportunity is limited to Boston Scientific due to FDA approval and distribution exclusivity

Description

Notice of Intent to Sole Source HT941026N0096

View original listing